Cargando…
Intravenous infusion of lidocaine enhances the efficacy of conventional treatment of postherpetic neuralgia
BACKGROUND: Postherpetic neuralgia (PHN) is one kind of severe neuropathic pain which currently cannot be effectively cured. Recent researches suggest that intravenous infusion of lidocaine has a therapeutic effect on neuropathic pain such as PHN; however, the optimal dose and frequency of lidocaine...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709377/ https://www.ncbi.nlm.nih.gov/pubmed/31686896 http://dx.doi.org/10.2147/JPR.S213128 |
_version_ | 1783446196170260480 |
---|---|
author | Tan, Xinran Ma, Lulin Yuan, Jie Zhang, Dexin Wang, Jie Zhou, Wenjing Cao, Song |
author_facet | Tan, Xinran Ma, Lulin Yuan, Jie Zhang, Dexin Wang, Jie Zhou, Wenjing Cao, Song |
author_sort | Tan, Xinran |
collection | PubMed |
description | BACKGROUND: Postherpetic neuralgia (PHN) is one kind of severe neuropathic pain which currently cannot be effectively cured. Recent researches suggest that intravenous infusion of lidocaine has a therapeutic effect on neuropathic pain such as PHN; however, the optimal dose and frequency of lidocaine infusion and the effectiveness and safety of this treatment in PHN patients still needs more clinical research. The aim of this study was to evaluate the therapeutic effects of daily intravenous lidocaine infusion on the outcome of the routine treatment of PHN. METHODS: Sixty PHN patients were randomly divided into two groups: 1) control group (Control), treated with conventional therapies, such as antiepileptic pills, analgesics, neurotrophic medicines, paravertebral spinal nerve block and physiotherapy; 2) lidocaine group (Lido) received daily infusion of lidocaine (4 mg/kg) besides the conventional treatments. If the pain is not controlled sufficiently, additional tramadol is given and the average consumption of tramadol is calculated. Pain intensity was assessed before and after each infusion, and the number of breakthrough pain in the last 24 hrs were recorded. The incidence of adverse reactions related to intravenous lidocaine infusion was recorded. RESULTS: For five consecutive days, numeric rating scale (NRS) scores were significantly decreased after 1 hr of intravenous infusion of lidocaine. Compared with Control, the NRS scores and the frequency of breakthrough pain in the Lido were significantly reduced. In addition, the extra tramadol consumption in the Lido was significantly lower than that in the Control, and the average hospital stay of patients in Lido was decreased. However, anxiety and depression scores showed no difference between Lido and Control. CONCLUSION: Daily intravenous lidocaine (4 mg/kg for 5 days) enhanced the outcome of PHN treatment, reduced the amount of analgesic medicine and shortened the length of hospital stay with no obvious adverse side effects. |
format | Online Article Text |
id | pubmed-6709377 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-67093772019-11-04 Intravenous infusion of lidocaine enhances the efficacy of conventional treatment of postherpetic neuralgia Tan, Xinran Ma, Lulin Yuan, Jie Zhang, Dexin Wang, Jie Zhou, Wenjing Cao, Song J Pain Res Original Research BACKGROUND: Postherpetic neuralgia (PHN) is one kind of severe neuropathic pain which currently cannot be effectively cured. Recent researches suggest that intravenous infusion of lidocaine has a therapeutic effect on neuropathic pain such as PHN; however, the optimal dose and frequency of lidocaine infusion and the effectiveness and safety of this treatment in PHN patients still needs more clinical research. The aim of this study was to evaluate the therapeutic effects of daily intravenous lidocaine infusion on the outcome of the routine treatment of PHN. METHODS: Sixty PHN patients were randomly divided into two groups: 1) control group (Control), treated with conventional therapies, such as antiepileptic pills, analgesics, neurotrophic medicines, paravertebral spinal nerve block and physiotherapy; 2) lidocaine group (Lido) received daily infusion of lidocaine (4 mg/kg) besides the conventional treatments. If the pain is not controlled sufficiently, additional tramadol is given and the average consumption of tramadol is calculated. Pain intensity was assessed before and after each infusion, and the number of breakthrough pain in the last 24 hrs were recorded. The incidence of adverse reactions related to intravenous lidocaine infusion was recorded. RESULTS: For five consecutive days, numeric rating scale (NRS) scores were significantly decreased after 1 hr of intravenous infusion of lidocaine. Compared with Control, the NRS scores and the frequency of breakthrough pain in the Lido were significantly reduced. In addition, the extra tramadol consumption in the Lido was significantly lower than that in the Control, and the average hospital stay of patients in Lido was decreased. However, anxiety and depression scores showed no difference between Lido and Control. CONCLUSION: Daily intravenous lidocaine (4 mg/kg for 5 days) enhanced the outcome of PHN treatment, reduced the amount of analgesic medicine and shortened the length of hospital stay with no obvious adverse side effects. Dove 2019-08-20 /pmc/articles/PMC6709377/ /pubmed/31686896 http://dx.doi.org/10.2147/JPR.S213128 Text en © 2019 Tan et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Tan, Xinran Ma, Lulin Yuan, Jie Zhang, Dexin Wang, Jie Zhou, Wenjing Cao, Song Intravenous infusion of lidocaine enhances the efficacy of conventional treatment of postherpetic neuralgia |
title | Intravenous infusion of lidocaine enhances the efficacy of conventional treatment of postherpetic neuralgia |
title_full | Intravenous infusion of lidocaine enhances the efficacy of conventional treatment of postherpetic neuralgia |
title_fullStr | Intravenous infusion of lidocaine enhances the efficacy of conventional treatment of postherpetic neuralgia |
title_full_unstemmed | Intravenous infusion of lidocaine enhances the efficacy of conventional treatment of postherpetic neuralgia |
title_short | Intravenous infusion of lidocaine enhances the efficacy of conventional treatment of postherpetic neuralgia |
title_sort | intravenous infusion of lidocaine enhances the efficacy of conventional treatment of postherpetic neuralgia |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709377/ https://www.ncbi.nlm.nih.gov/pubmed/31686896 http://dx.doi.org/10.2147/JPR.S213128 |
work_keys_str_mv | AT tanxinran intravenousinfusionoflidocaineenhancestheefficacyofconventionaltreatmentofpostherpeticneuralgia AT malulin intravenousinfusionoflidocaineenhancestheefficacyofconventionaltreatmentofpostherpeticneuralgia AT yuanjie intravenousinfusionoflidocaineenhancestheefficacyofconventionaltreatmentofpostherpeticneuralgia AT zhangdexin intravenousinfusionoflidocaineenhancestheefficacyofconventionaltreatmentofpostherpeticneuralgia AT wangjie intravenousinfusionoflidocaineenhancestheefficacyofconventionaltreatmentofpostherpeticneuralgia AT zhouwenjing intravenousinfusionoflidocaineenhancestheefficacyofconventionaltreatmentofpostherpeticneuralgia AT caosong intravenousinfusionoflidocaineenhancestheefficacyofconventionaltreatmentofpostherpeticneuralgia |